HIV drugs - Life Sciences bibliographies - in Harvard style

In-text: (Burch et al., 2009)

Your Bibliography: Burch, J., Corbett, M., Stock, C., Nicholson, K., Elliot, A., Duffy, S., Westwood, M., Palmer, S. and Stewart, L., 2009. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. The Lancet Infectious Diseases, 9(9), pp.537-545.

In-text: (Cann and Karn, 1989)

Your Bibliography: Cann, A. and Karn, J., 1989. Molecular biology of HIV. Aids, 3(Supplement), pp.S19-34.

In-text: (Craigie, 2001)

Your Bibliography: Craigie, R., 2001. HIV Integrase, a Brief Overview from Chemistry to Therapeutics. Journal of Biological Chemistry, 276(26), pp.23213-23216.

In-text: (Das, Martinez, Bauman and Arnold, 2012)

Your Bibliography: Das, K., Martinez, S., Bauman, J. and Arnold, E., 2012. HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat Struct Mol Biol, 19(2), pp.253-259.

In-text: (Davies, 1990)

Your Bibliography: Davies, D., 1990. The Structure and Function of the Aspartic Proteinases. Annu. Rev. Biophys. Biophys. Chem., 19(1), pp.189-215.

In-text: (Hare et al., 2010)

Your Bibliography: Hare, S., Gupta, S., Valkov, E., Engelman, A. and Cherepanov, P., 2010. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature, 464(7286), pp.232-236.

In-text: (hio Shibagaki and Chow, 1997)

Your Bibliography: hio Shibagaki, Y. and Chow, S., 1997. Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection. Journal of Biological Chemistry, 272(13), pp.8361-8369.

In-text: (Huff, 1991)

Your Bibliography: Huff, J., 1991. HIV protease: a novel chemotherapeutic target for AIDS. Journal of Medicinal Chemistry, 34(8), pp.2305-2314.

In-text: (Kewn et al., 1997)

Your Bibliography: Kewn, S., Veal, G., Hoggard, P., Barry, M. and Back, D., 1997. Lamivudine (3TC) phosphorylation and drug interactions in vitro. Biochemical Pharmacology, 54(5), pp.589-595.

In-text: (Kohl et al., 1988)

Your Bibliography: Kohl, N., Emini, E., Schleif, W., Davis, L., Heimbach, J., Dixon, R., Scolnick, E. and Sigal, I., 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proceedings of the National Academy of Sciences, 85(13), pp.4686-4690.

In-text: (Lukic et al., 2014)

Your Bibliography: Lukic, Z., Dharan, A., Fricke, T., Diaz-Griffero, F. and Campbell, E., 2014. HIV-1 Uncoating Is Facilitated by Dynein and Kinesin 1. Journal of Virology, 88(23), pp.13613-13625.

In-text: (Matthews et al., 2004)

Your Bibliography: Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R. and Bolognesi, D., 2004. Case history: Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Nat Rev Drug Discov, 3(3), pp.215-225.

In-text: (Pattman, 2010)

Your Bibliography: Pattman, R., 2010. Oxford handbook of genitourinary medicine, HIV, and sexual health. Oxford: Oxford University Press.

In-text: (Rang and Dale, 2012)

Your Bibliography: Rang, H. and Dale, M., 2012. Rang and Dale's pharmacology. Edinburgh: Elsevier/Churchill Livingstone.

In-text: (Sarafianos et al., 2009)

Your Bibliography: Sarafianos, S., Marchand, B., Das, K., Himmel, D., Parniak, M., Hughes, S. and Arnold, E., 2009. Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition. Journal of Molecular Biology, 385(3), pp.693-713.

In-text: (Spence, Kati, Anderson and Johnson, 1995)

Your Bibliography: Spence, R., Kati, W., Anderson, K. and Johnson, K., 1995. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science, 267(5200), pp.988-993.

In-text: (Stein and Moore, 2001)

Your Bibliography: Stein, D. and Moore, K., 2001. Phosphorylation of Nucleoside Analog Antiretrovirals: A Review for Clinicians. Pharmacotherapy, 21(1), pp.11-34.

In-text: (Svicher et al., 2011)

Your Bibliography: Svicher, V., Balestra, E., Cento, V., Sarmati, L., Dori, L., Vandenbroucke, I., D’Arrigo, R., Buonomini, A., Van Marck, H., Surdo, M., Saccomandi, P., Mostmans, W., Aerssens, J., Aquaro, S., Stuyver, L., Andreoni, M., Ceccherini-Silberstein, F. and Perno, C., 2011. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. Antiviral Research, 90(1), pp.42-53.

In-text: (Yost, Pasquale and Sahloff, 2009)

Your Bibliography: Yost, R., Pasquale, T. and Sahloff, E., 2009. Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection. American Journal of Health-System Pharmacy, 66(8), pp.715-726.

In-text: (Zhu et al., 2008)

Your Bibliography: Zhu, P., Winkler, H., Chertova, E., Taylor, K. and Roux, K., 2008. Cryoelectron Tomography of HIV-1 Envelope Spikes: Further Evidence for Tripod-Like Legs. PLoS Pathogens, 4(11), p.e1000203.